financetom
Business
financetom
/
Business
/
Invivyd Selects Antibody Candidate for Respiratory Syncytial Virus Prevention
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Invivyd Selects Antibody Candidate for Respiratory Syncytial Virus Prevention
Nov 24, 2025 5:06 AM

07:47 AM EST, 11/24/2025 (MT Newswires) -- Invivyd ( IVVD ) said Monday it has nominated its VBY329 investigational antibody for the prevention of respiratory syncytial virus among neonates, infants, and children for preclinical development.

The company expects to present in vitro VBY329 data at a future medical congress.

Invivyd ( IVVD ) said it expects to advance VBY329 toward investigational new drug application readiness in H2 2026 for development in pediatric RSV prophylaxis.

The company's shares were up 1.2% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Iren Fiscal Q3 Earnings, Revenue Rise
Iren Fiscal Q3 Earnings, Revenue Rise
May 26, 2025
04:54 PM EDT, 05/14/2025 (MT Newswires) -- Iren ( IREN ) reported fiscal Q3 EPS late Wednesday of $0.11, up from $0.08 a year earlier. Revenue for the quarter ended March 31 was $148.10 million, up from $54.35 million a year earlier. Analysts surveyed by FactSet expected $152 million. ...
Navigator Holdings Q1 Adjusted Earnings, Revenue Rise; Authorizes New Repurchase Program
Navigator Holdings Q1 Adjusted Earnings, Revenue Rise; Authorizes New Repurchase Program
May 26, 2025
04:54 PM EDT, 05/14/2025 (MT Newswires) -- Navigator Holdings ( NVGS ) reported Q1 adjusted earnings late Wednesday of $0.36 per diluted share, up from $0.32 a year earlier. Three analysts surveyed by FactSet expected $0.32. Revenue for the quarter ended March 31 was $151.4 million, up from $134.2 million a year earlier. Analysts polled by FactSet expected $134.4 million....
Blaize Q1 Loss Widens, Revenue Increases; Sets Full-Year Guidance
Blaize Q1 Loss Widens, Revenue Increases; Sets Full-Year Guidance
May 26, 2025
04:50 PM EDT, 05/14/2025 (MT Newswires) -- Blaize ( BZAI ) reported a Q1 loss of $1.61 per diluted share, widening from a loss of $1.23 a year earlier. Three analysts polled by FactSet expected a loss of $0.15. Revenue for the quarter ended March 31 was $1 million, up from $549,000 a year earlier. Three analysts surveyed by FactSet...
Copyright 2023-2026 - www.financetom.com All Rights Reserved